Stay updated on Apremilast in Nummular Eczema Clinical Trial

Sign up to get notified when there's something new on the Apremilast in Nummular Eczema Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Apremilast in Nummular Eczema Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The screenshots show only minor visual/layout adjustments; the core study details appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T21:01:46.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    30 days ago
    Change Detected
    Summary
    The page is updated to v3.2.0 and adds a government operating-status notice, replacing the previous v3.1.0 reference.
    Difference
    4%
    Check dated 2025-10-06T05:27:28.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    Page now shows revision to v3.1.0 and removes several drug-safety-related topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) from the content, indicating a shift away from those topics while adding a new version.
    Difference
    0.4%
    Check dated 2025-09-29T03:04:18.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2; the Back to Top link was removed.
    Difference
    0.2%
    Check dated 2025-09-14T19:07:11.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-07T15:16:13.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, as well as updates to MedlinePlus related topics, particularly concerning drug safety and counterfeit drugs. Notably, several previous topics and terms related to apremilast and various pharmacological classifications have been removed.
    Difference
    4%
    Check dated 2025-08-31T11:49:37.000Z thumbnail image

Stay in the know with updates to Apremilast in Nummular Eczema Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Apremilast in Nummular Eczema Clinical Trial page.